Published in Gene Therapy Weekly, March 1st, 2012
"Different expression levels were achieved by using retroviral vectors equipped with different strength promoters. Cells were 'shotgun' transduced with a mixture of these vectors to generate heterogeneous populations...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly